免费专区
专家公益课堂
优质好文收藏推荐
书籍大全购买推荐
全球产品信息快览
机构专区
德国国立杜易斯堡埃森大学IMC口腔医学院大中华区代表处
西班牙CEU圣保罗大学基金会亚太代表处
The American Association of Aesthetic Medicine and Surgery (AAAMS)
关于我们
免费专区
专家公益课堂
优质好文收藏推荐
书籍大全购买推荐
全球产品信息快览
机构专区
德国国立杜易斯堡埃森大学IMC口腔医学院大中华区代表处
西班牙CEU圣保罗大学基金会亚太代表处
The American Association of Aesthetic Medicine and Surgery (AAAMS)
关于我们
登录
注册
登录
注册
文献包 - 皮肤填充剂治疗 Dermal Fillers
第38任务: DF 0374-New-generation filler based on cross-linked carboxymethylcellulose study of 350 patients with 3-year follow-up
查看课程
任务列表
第1任务: DF 0066-Autologous Fat Grafting for Treating
第2任务: DF 0057-Safety and Effectiveness of Juvéderm Ultra Plus
第3任务: DF 0038-Juvéderm Volbella with Lidocaine for Lip
第4任务: DF 0036-Discussion Juvéderm Volbella with Lidocaine for
第5任务: DF 0027-The Facial Contouring and Support System
第6任务: DF 0023-Global Updates on the Future Directions of
第7任务: DF 0022-Patient Reported Outcomes following Split Face
第8任务: DF 0007-Autologous Fat Transfer for Facial Rejuvenation A Systematic Review on Technique, Efficacy, and Satisfaction
第9任务: DF 0006-Perpendicular Strut Injection of Hyaluronic Acid
第10任务: DF 0005-Ultrasound and Histologic Examination after
第11任务: DF 0425-Invited Discussion on—The Injection for the Lower Eyelid Retraction- A Mechanical Analysis of the Lifting Effect of the Hyaluronic Acid
第12任务: DF 0423-The Injection for the Lower Eyelid Retraction- A Mechanical Analysis of the Lifting Effect of the Hyaluronic Acid
第13任务: DF 0422-A Randomized, Controlled, Multicenter Study of Juvéderm Voluma for Enhancement of Malar Volume in Chinese Subjects
第14任务: DF 0420-Consensus Recommendations for Treatment Strategies in Indians Using Botulinum Toxin and Hyaluronic Acid Fillers
第15任务: DF 0416-The Use of Hyaluronidase in Aesthetic Practice (v2.4)
第16任务: DF 0415-Hyaluronan More than just a wrinkle filler
第17任务: DF 0410-Use of calcium hydroxylapatite (Radiesse®) for facial augmentation
第18任务: DF 0409-Treatment of Age-related Mid-face Atrophy by Injection of Cohesive Polydensified Matrix Hyaluronic Acid Volumizer
第19任务: DF 0407-Functionalizable hydrogel microparticles of tunable size and stiffness for soft-tissue filler applications
第20任务: DF 0406-What’s New in Fillers in 2010
第21任务: DF 0405-Investigation of the Degradation-Retarding Effect Caused by the Low Swelling Capacity of a Novel Hyaluronic Acid Filler Developed by Solid-Phase Crosslinking Technology
第22任务: DF 0403-Complete biodegradable nature of calcium hydroxylapatite after injection for malar enhancement an MRI study
第23任务: DF 0402-Acquired facial lipoatrophy pathogenesis and therapeutic options
第24任务: DF 0400-Efficacy and Safety of a Hyaluronic Acid Filler to Correct Aesthetically Detracting or Deficient Features of the Asian Nose A Prospective, Open-Label, Long-Term Study
第25任务: DF 0398-Injectable Shape-Memorizing Three-Dimensional Hyaluronic Acid Cryogels for Skin Sculpting and Soft Tissue Reconstruction
第26任务: DF 0397-Technical Considerations for Filler and Neuromodulator Refinements
第27任务: DF 0396-The Use of Type I and Type III Injectable Human Collagen for Dermal Fill 10 Years of Clinical Experience in China
第28任务: DF 0394-Body vectoring technique with Radiesse® for tightening of the abdomen, thighs, and brachial zone
第29任务: DF 0391-The Efficacy, Longevity, and Safety of Combined Radiofrequency Treatment and Hyaluronic Acid Filler for Skin Rejuvenation
第30任务: DF 0389-Facial rejuvenation for middle-aged women a combined approach with minimally invasive procedures
第31任务: DF 0388-ArteFill Permanent Injectable for Soft Tissue Augmentation II. Indications and Applications
第32任务: DF 0386-The Surgical Lips Deformity Corrected with Hyaluronic Fillers A Case Report
第33任务: DF 0385-Effectiveness evaluation of two volumizing hyaluronic acid dermal fillers in a controlled, randomized, double-blind, split-face clinical study
第34任务: DF 0380-Safety and performance of cohesive polydensified matrix hyaluronic acid fillers with lidocaine in the clinical setting – an open-label, multicenter study
第35任务: DF 0379-Vapocoolant Anesthesia for Cosmetic Facial Rejuvenation Injections A Randomized, Prospective, Split-Face Trial
第36任务: DF 0377-Randomized, Evaluator-Blinded Study Comparing Safety and Effect of Two Hyaluronic Acid Gels for Lips Enhancement
第37任务: DF 0375-Impact on facial rejuvenation with dermatological preparations
第38任务: DF 0374-New-generation filler based on cross-linked carboxymethylcellulose study of 350 patients with 3-year follow-up
第39任务: DF 0373-A Multicenter, Single-Blind Randomized, Controlled Study of a Volumizing Hyaluronic Acid Filler for Midface Volume Deficit PatientReported Outcomes at 2 Years
第40任务: DF 0372-Improvement of Tear Trough by Monophasic Hyaluronic Acid and Calcium Hydroxylapatite
第41任务: DF 0371-Effect of molecular weight of hyaluronic acid (HA) on viscoelasticity and particle texturing feel of HA dermal biphasic fillers
第42任务: DF 0370-Cohesion of Hyaluronic Acid Fillers Correlation Between Cohesion and Other Physicochemical Properties
第43任务: DF 0368-Dermal Filler Injection A Novel Approach for Limiting Infarct Expansion
第44任务: DF 0365-Development and characterization of a rapid polymerizing collagen for soft tissue augmentation
第45任务: DF 0364-Calcium Hydroxylapatite Over a Decade of Clinical Experience
第46任务: DF 0363-The Effect of Incobotulinumtoxin A and Dermal Filler Treatment on Perception of Age, Health, and Attractiveness of Female Faces
第47任务: DF 0361-A comparison of the efficacy, safety, and longevity of two different hyaluronic acid dermal fillers
第48任务: DF 0360-Duration of wrinkle correction following repeat treatment with Juve´derm hyaluronic acid fillers
第49任务: DF 0359-A Review of the Metabolism of 1,4-Butanediol Diglycidyl Ether–Crosslinked Hyaluronic Acid Dermal Fillers
第50任务: DF 0358-STYLAGE® a range of hyaluronic acid dermal fillers containing mannitol. Physical properties and review of the literature
第51任务: DF 0331-A prospective, open-label, multicenter, observational, postmarket study of the use of a 15 mg mL hyaluronic acid dermal filler in the lips
第52任务: DF 0329-Are joint and soft tissue injections painful Results of a national French cross-sectional study of procedural pain in rheumatological practice
第53任务: DF 0328-High-density Hyaluronic Acid for the Treatment of HIV-related Facial Lipoatrophy
第54任务: DF 0327-Noninvasive Facial Rejuvenation. Part 2 Physician-Directed—Neuromodulators and Fillers
第55任务: DF 0325-A phosphatidylcholine hyaluronic acid chitin–nanofibrils complex for a fast skin remodeling and a rejuvenating look
第56任务: DF 0324-Efficacy of a New Topical Nano-hyaluronic Acid in Humans
第57任务: DF 0322-Minimal recovery time needed to return to social engagement following nasolabial fold correction with hyaluronic acid fillers produced with XpresHAn technology
第58任务: DF 0321-Dental Procedures Is it a Risk Factor for Injectable Dermal Fillers
第59任务: DF 0319-Nonsurgical Rejuvenation of the Eyelids with Hyaluronic Acid Gel Injections
第60任务: DF 0316-Evaluating Perceived Naturalness of Facial Expression After Fillers to the Nasolabial Folds and Lower Face With Standardized Video and Photography
第61任务: DF 0313-Combining Microfocused Ultrasound With Botulinum Toxin and Temporary and Semi-Permanent Dermal Fillers Safety and Current Use
第62任务: DF 0312-Persistence of Nasolabial Fold Correction with a Hyaluronic Acid Dermal Filler with Retreatment Results of an 18-Month Extension Study
第63任务: DF 0311-Comparison of Smooth Gel Hyaluronic Acid Dermal Fillers with Cross-linked Bovine Collagen A Multicenter Double-Masked Randomized Within-Subject Study
第64任务: DF 0310-Perpendicular Strut Injection of Hyaluronic Acid Filler for Deep Wrinkles
第65任务: DF 0297-Correction of a Hollow Lower Eyelid with
第66任务: DF 0287-Universal and Ethnic specific Considerations on
第67任务: DF 0189-Fat Grafting to the Forehead Glabella
第68任务: DF 0115-Three dimensional Facial Anatomy Structure
第69任务: DF 0083-Nasal Reshaping with Hyaluronic Acid
第70任务: DF 0070-Application of Microautologous Fat Transplantation
第71任务: DF 0333-Hyaluronic acid dermal fillers can adjunctive lidocaine improve patient satisfaction without decreasing efficacy or duration
第72任务: DF 0332-Long-term efficacy, safety and durability of Juvéderm® XC
第73任务: DF 0349-Counseling patients on facial volume replacement and adherence with posttreatment instructions
第74任务: DF 0348-Review of long-term adverse effects associated with the use of chemically-modifi ed animal and nonanimal source hyaluronic acid dermal fi llers
第75任务: DF 0347-Hyaluronic acid gel fi llers in the management of facial aging
第76任务: DF 0346-Review of soft tissue augmentation in the face
第77任务: DF 0345-The Use of a Contact Cooling Device to Reduce Pain and Ecchymosis Associated With Dermal Filler Injections
第78任务: DF 0344-Hyaluronic acid fillers with cohesive polydensified matrix for soft-tissue augmentation and rejuvenation a literature review
第79任务: DF 0342-MRI in detecting facial cosmetic injectable fillers
第80任务: DF 0341-Injectable facial fillers imaging features, complications, and diagnostic pitfalls at MRI and PET CT
第81任务: DF 0339-Lip Augmentation Dermal Filler Reactions, Histopathologic Features
第82任务: DF 0338-Treatment of Soft Tissue Filler Complications Expert Consensus Recommendations
第83任务: DF 0337-Trends in the Use of Neurotoxins and Dermal Fillers by US Physicians
第84任务: DF 0336-Investigation of Physical Properties of a Polycaprolactone Dermal Filler when Mixed with Lidocaine and Lidocaine Epinephrine
第85任务: DF 0335-Foreign Body Granulomas after the Use of Dermal Fillers Pathophysiology, Clinical Appearance, Histologic Features, and Treatment
第86任务: DF 0334-Applications and Emerging Trends of Hyaluronic Acid in Tissue Engineering, as a Dermal Filler, and in Osteoarthritis Treatment
第87任务: DF 0356-Hyaluronic acid gel ( Juvéderm™) preparations in the treatment of facial wrinkles and folds
第88任务: DF 0354-Consensus on Current Injectable Treatment Strategies in the Asian Face
第89任务: DF 0352-A Prospective, Open-Label, Observational, Postmarket Study Evaluating VYC-17.5L for the Correction of Moderate to Severe Nasolabial Folds Over 12 Months
第90任务: DF 0351-Global Aesthetics Consensus Hyaluronic Acid Fillers and Botulinum Toxin Type A—Recommendations for Combined Treatment and Optimizing Outcomes in Diverse Patient Populations